Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression - A role in the immune tolerance to antigenic tumors

被引：0
|
作者：
Chaux, P
Favre, N
Bonnotte, B
Moutet, M
Martin, M
Martin, F
机构：
来源：
DENDRITIC CELLS IN FUNDAMENTAL AND CLINICAL IMMUNOLOGY, VOL 3 | 1997年 / 417卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：525 / 528
页数：4
相关论文
共 30 条
  • [1] Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats
    Chaux, P
    Favre, N
    Martin, M
    Martin, F
    INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (04) : 619 - 624
  • [2] MISSING B7 IN A PART OF ANTIGEN-PRESENTING CELLS INFILTRATING GLIOBLASTOMA MULTIFORME
    Tumangelova-Yuzeir, Kalina
    Ivanova-Todorova, Ekaterina
    Nachev, Sevdalin
    Velikova, Tsvetelina
    Naydenov, Emanuil
    Kyurkchiev, Dobroslav
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2014, 67 (07): : 1015 - 1020
  • [3] Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells
    Lohse, AW
    Knolle, PA
    Bilo, K
    Uhrig, A
    Waldmann, C
    Ibe, M
    Schmitt, E
    Gerken, G
    ZumBuschenfelde, KHM
    GASTROENTEROLOGY, 1996, 110 (04) : 1175 - 1181
  • [4] Role of tumor-infiltrating CD11b+ antigen-presenting cells in the progression of gastric cancer
    Okita, Yoshihiro
    Tanaka, Hiroaki
    Ohira, Masaichi
    Muguruma, Kazuya
    Kubo, Naoshi
    Watanabe, Mao
    Fukushima, Wakaba
    Hirakawa, Kosei
    JOURNAL OF SURGICAL RESEARCH, 2014, 186 (01) : 192 - 200
  • [5] Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection
    Preynat-Seauve, O
    Schuler, P
    Contassot, E
    Beermann, F
    Huard, B
    French, LE
    JOURNAL OF IMMUNOLOGY, 2006, 176 (01): : 61 - 67
  • [6] Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients
    GarciaCozar, FJ
    Molina, IJ
    Cuadrado, MJ
    Marubayashi, M
    Pena, J
    Santamaria, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (01): : 72 - 79
  • [7] An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
    Ye, Kai
    Li, Fan
    Wang, Ruikun
    Cen, Tianyi
    Liu, Shiyu
    Zhao, Zhuoqian
    Li, Ruonan
    Xu, Lili
    Zhang, Guanmeng
    Xu, Zhaoyuan
    Deng, Li
    Li, Lili
    Wang, Wei
    Stepanov, Alexey
    Wan, Yajuan
    Guo, Yu
    Li, Yuanke
    Wang, Yuan
    Tian, Yujie
    Gabibov, Alexander G.
    Yan, Yingbin
    Zhang, Hongkai
    MOLECULAR THERAPY, 2022, 30 (12) : 3658 - 3676
  • [8] INSITU EXPRESSION OF B7/BB1 ON ANTIGEN-PRESENTING CELLS AND ACTIVATED B-CELLS - AN IMMUNOHISTOCHEMICAL STUDY
    VANDENBERGHE, P
    DELABIE, J
    DEBOER, M
    DEWOLFPEETERS, C
    CEUPPENS, JL
    INTERNATIONAL IMMUNOLOGY, 1993, 5 (03) : 317 - 321
  • [9] Graves' Disease Is Associated with a Defective Expression of the Immune Regulatory Molecule Galectin-9 in Antigen-Presenting Dendritic Cells
    Leskela, Susanna
    Serrano, Ana
    de la Fuente, Hortensia
    Rodriguez-Munoz, Ana
    Ramos-Levi, Ana
    Sampedro-Nunez, Miguel
    Sanchez-Madrid, Francisco
    Gonzalez-Amaro, Roberto
    Marazuela, Monica
    PLOS ONE, 2015, 10 (04):
  • [10] Maturation of cytotoxic T lymphocytes against a B7-transfected nonmetastatic tumor: A critical role for costimulation by B7 on both tumor and nest antigen-presenting cells
    Maric, M
    Zheng, P
    Sarma, S
    Guo, Y
    Liu, Y
    CANCER RESEARCH, 1998, 58 (15) : 3376 - 3384
123